(Q34411415)

2 August 2017

5 references

19 September 2019

2 October 2019

21 July 2020

26 November 2020

30 January 2021

0 references

Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis (English)

1 reference

biomedical investigative technique

2 August 2017

0 references

1 reference

19 September 2019

1 reference

2 October 2019

2 references

21 July 2020

30 January 2021

population surveillance

1 reference

26 November 2020

1 reference

David Prieto-Merino

5

0 references

Shah Ebrahim

6

object named as

Shah Ebrahim

1 reference

2 August 2017

Ana Filipa Macedo

1

1 reference

2 August 2017

Fiona Claire Taylor

2

1 reference

2 August 2017

Juan P Casas

3

1 reference

2 August 2017

Alma Adler

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

22 March 2014

6 references

2 August 2017

19 September 2019

2 October 2019

21 July 2020

26 November 2020

30 January 2021

6 references

2 August 2017

19 September 2019

2 October 2019

21 July 2020

26 November 2020

30 January 2021

12

1 reference

2 August 2017

page(s)

51

1 reference

Creative Commons Attribution 2.0 Generic

2 August 2017

copyright license

5 references

19 September 2019

2 October 2019

21 July 2020

26 November 2020

Statins and cognitive function: a systematic review

30 January 2021

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and cognition: a systematic review and meta-analysis of short- and long-term cognitive effects

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246 955 participants from 135 randomized, controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins in the primary prevention of cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Risk of incident diabetes among patients treated with statins: population based study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for the primary prevention of cardiovascular disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The impact of statins on psychological wellbeing: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effect of statins on skeletal muscle function

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The effect of rosuvastatin on incident pneumonia: results from the JUPITER trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for age-related macular degeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Sensitivity and precision of adverse effects search filters in MEDLINE and EMBASE: a case study of fractures with thiazolidinediones.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cholesterol-lowering drugs and incident open-angle glaucoma: a population-based cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for multiple sclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for primary prevention of venous thromboembolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and associated risk of pneumonia: a systematic review and meta-analysis of observational studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and intracerebral hemorrhage: collaborative systematic review and meta-analysis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The prevalence of hearing impairment and associated risk factors: the Beaver Dam Offspring Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Differential metabolic effects of distinct statins.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and decreased risk of benign prostatic enlargement and lower urinary tract symptoms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for the treatment of dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and Parkinson's disease in Denmark

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Age-varying association between statin use and incident Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and risk of amyotrophic lateral sclerosis and other motor neuron disorders

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Influenza morbidity and mortality in elderly patients receiving statins: a cohort study.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Does statin use improve pneumonia outcomes?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Withdrawal of statins and risk of subarachnoid hemorrhage

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Do statins protect against upper gastrointestinal bleeding?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and the risk of cholecystectomy in women

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effect of statins on a wide range of health outcomes: a cohort study validated by comparison with randomized trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and the risk of Parkinson disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lipid-lowering agents and the risk of cognitive impairment that does not meet criteria for dementia, in relation to apolipoprotein E status.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Association of statin use with cognitive decline in elderly African Americans

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Does statin therapy initiation increase the risk for myopathy? An observational study of 32,225 diabetic and nondiabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin and statin-fibrate use was significantly associated with increased myositis risk in a managed care population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The safety of statins in clinical practice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and the five-year incidence and progression of age-related macular degeneration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cardiovascular diseases and the risk of venous thromboembolism: a hospital-based case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and fracture risk. A systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lower low-density lipoprotein cholesterol levels are associated with Parkinson's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin use and incident nuclear cataract

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for improving renal outcomes: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statin safety: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

A case control study of age related macular degeneration and use of statins.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Do statins increase the risk of idiopathic polyneuropathy?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and newly diagnosed diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Hypercholesterolemia, HMG-CoA reductase inhibitors, and risk of intracerebral hemorrhage: a case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lipid-lowering drugs and the risk of depression and suicidal behavior

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

The association between statin use and age related maculopathy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cataract and the use of statins: a case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Lipid-lowering agents and the risk of hip fracture in a Medicaid population

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and risk of polyneuropathy: a case-control study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and the risk of idiopathic venous thromboembolism

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins for the reduction of risk of Alzheimer's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Risk of cataract in patients treated with statins.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Statins and the risk of dementia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

HMG-CoA reductase inhibitors and the risk of fractures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Clinical outcomes in statin treatment trials: a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Meta-analysis: principles and procedures

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Reporting of Safety Results in Published Reports of Randomized Controlled Trials

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins for people at low risk of cardiovascular disease – Authors' reply

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin use and depressive symptoms in a prospective study of community-living older persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins and cognitive function in the elderly: the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Long-term statin use and the risk of gallstone disease: A population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

An assessment of the effect of statin use on the incidence of acute respiratory infections in England during winters 1998-1999 to 2005-2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin use and the risk of Alzheimer's disease: the MIRAGE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins are associated with a reduced risk of Alzheimer disease regardless of lipophilicity. The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Hyperlipidaemia, statin use and the risk of developing rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Relation of Statin Use to the 5-Year Incidence and Progression of Age-Related Maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the Cardiovascular Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Cerebrovascular risk factors and incident depression in community-dwelling elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins and other cholesterol-lowering medications and the presence of glaucoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Hypotensive medication, statins, and the risk of glaucoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin Use and the Risk of Incident Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins and the risk of pneumonia: a population-based, nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

HMG-CoA reductase inhibitors and the risk of vertebral fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin use and fracture risk: study of a US veterans population

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Serum total cholesterol, statins and cognition in non-demented elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Effect of statins on the development of renal dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statin use and the long-term risk of incident cataract: the Blue Mountains Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Statins and the long-term risk of incident age-related macular degeneration: the Blue Mountains Eye Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Use of statins and risk of fractures

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1741-7015-12-51

Hip fracture risk in statin users--a population-based Danish case-control study.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3998050

Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women

27 October 2018

1 reference

12 December 2020

Statins and Musculoskeletal Conditions, Arthropathies, and Injuries

1 reference

12 December 2020

Statin use and incident frailty in women aged 65 years or older: prospective findings from the Women's Health Initiative Observational Study

1 reference

12 December 2020

Use of statins is associated with an increased risk of rheumatoid arthritis

1 reference

12 December 2020

Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study

1 reference

12 December 2020

HMG-CoA reductase inhibitors, other lipid-lowering medication, antiplatelet therapy, and the risk of venous thrombosis

1 reference

12 December 2020

Statin use and risk of gastroduodenal ulcer and reflux esophagitis

1 reference

12 December 2020

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

1 reference

12 December 2020

HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients

1 reference

12 December 2020

Cholesterol-lowering medications reduce the risk of age-related maculopathy progression

1 reference

12 December 2020

Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom

1 reference

12 December 2020

Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

1 reference

12 December 2020

Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study

1 reference

12 December 2020

Association between statin use and Alzheimer's disease

1 reference

12 December 2020

3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study

1 reference

12 December 2020

Identifiers

DOI

10.1186/1741-7015-12-51

1 reference

2 August 2017

1 reference

2 August 2017

1 reference